Evidence map›Paper›PMID 30340603›Full record

ArticleJournal of orthopaedic surgery and research2018

The potent anti-inflammatory effect of Guilu Erxian Glue extracts remedy joint pain and ameliorate the progression of osteoarthritis in mice.

Yen-Jung Chou, Jiunn-Jye Chuu, Yi-Jen Peng, Yu-Hsuan Cheng, Chin-Hsien Chang, Chieh-Min Chang, Hsia-Wei Liu

Open access · goldAbstract read
In one paragraph

Article in Journal of orthopaedic surgery and research, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 24 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Guilu-Erxian-Glue alleviatesPharmaceutical biology · 2023
    Article
  8. Article
  9. Article
  10. Effects ofIranian journal of pharmaceutical research : IJPR · 2022
    Article
  11. Article
  12. Healthcare and Scientific Treatment of Knee Osteoarthritis.Journal of healthcare engineering · 2022
    Review
  13. Article
  14. Article
  15. Review
  16. Effective Dose ofFrontiers in pharmacology · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 6 institutions in 1 country.

Yen-Jung ChouDepartment of Traditional Chinese Medicine, MacKay Memorial Hospital, Taipei City, Taiwan.
Jiunn-Jye ChuuDepartment of Biotechnology, College of Engineering, Southern Taiwan University, Tainan City, Taiwan.
Yi-Jen PengDepartment of Pathology, Tri-Service General Hospital, National Defense Medical Center, Taipei City, Taiwan.
Yu-Hsuan ChengDepartment of Biotechnology, College of Engineering, Southern Taiwan University, Tainan City, Taiwan.
Chin-Hsien ChangDepartment of Cosmetic Science, Chang Gung University of Science and Technology, Tao-Yuan City, Taiwan.
Chieh-Min ChangDepartment of Traditional Chinese Medicine, En Chu Kong Hospital, New Taipei City, 237, Taiwan.
Hsia-Wei LiuDepartment of Life Science, Fu Jen Catholic University, New Taipei City, Taiwan. 079336@gmail.com.
Southern Taiwan University of Science and Technology · TWChang Gung University of Science and Technology · TWEn Chu Kong Hospital · TWFu Jen Catholic University · TWMackay Memorial Hospital · TWTri-Service General Hospital · TW

Funding

En Chu Kong Hospital ECKH10307 and no. ECKH10411Mackay Memorial Hospital (TW) no. MMH10406
6 · The paper itself

Abstract

backgroundOsteoarthritis (OA) is a slow progressing, degenerative disorder of the synovial joints. Guilu Erxian Glue (GEG) is a multi-component Chinese herbal remedy with long-lasting favorable effects on several conditions, including articular pain and muscle strength in elderly men with knee osteoarthritis. The present study aimed to identify the effects of Guilu Erxian Paste (GE-P) and Liquid (GE-L) extracted from Guilu Erxian Glue in anterior cruciate ligament transection (ACLT)-induced osteoarthritis mice, and to compare the effectiveness of different preparations on knee cartilage degeneration during the progression of osteoarthritis.

methodsMale C57BL/6J mice underwent anterior cruciate ligament transection to induce mechanically destabilized osteoarthritis in the right knee. 4 weeks later, the mice were orally treated with PBS, celecoxib (10 mg/kg/day), Guilu Erxian Paste (100 or 300 mg/kg/day), and Guilu Erxian Liquid (100 or 300 mg/kg/day) for 28 consecutive days. Von Frey and open-field tests (OFT) were used to evaluate pain behaviors (mechanical hypersensitivity and locomotor performance). Narrowing of the joint space and osteophyte formation were examined radiographically. Inflammatory cytokine (IL-1β, IL-6, and TNF-α) levels in the articular cartilage were determined by quantitative real-time PCR. Histopathological examinations were conducted to evaluate the severity and extent of the cartilage lesions.

resultsGuilu Erxian Paste and Guilu Erxian Liquid (300 mg/kg/day) were significantly more effective (p < 0.01) than celecoxib (10 mg/kg/day) in decreasing secondary allodynia when compared to the saline-treated group (

conclusionsAs expected, our findings suggest that the anti-inflammatory effects of Guilu Erxian Liquid (GE-L), following marked decrease on both IL-1β and TNF-α during the early course of post-traumatic osteoarthrosis (OA), may be of potential value in the treatment of osteoarthritis.

Indexed as

AnimalsAnti-Inflammatory Agents, Non-SteroidalArthritis, ExperimentalCartilage, ArticularCytokinesDisease ProgressionDrug Evaluation, PreclinicalDrugs, Chinese HerbalGene Expression RegulationInflammation MediatorsMaleMice, Inbred C57BLMotor ActivityOsteoarthritisOsteolysisRadiographyAnti-Inflammatory Agents, Non-SteroidalCytokinesDrugs, Chinese HerbalInflammation MediatorsAnterior cruciate ligamentArticular cartilageGuilu Erxian GlueKneeMiceOsteoarthritis

Identifiers

PMID30340603
PMCPMC6194592
OpenAlexW2896280025

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.